Adult Autoimmune Myopathies (MAIA)

Not Applicable

Recruiting

• Conditions: Idiopathic Inflammatory Myopathies
• Interventions: Other: description of adult autoimmune myopathies

• Registration Number: NCT04792931
• Lead Sponsor: University Hospital, Brest

Brief Summary

This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-03-08
• Study First Submitted QC: 2021-03-10
• Study First Posted: 2021-03-11
• Study Start: 2022-05-20
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-04
• Last Update Posted: 2025-02-05
• Primary Completion: 2030-05-20
• Study Completion: 2030-05-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Clinical suspicion of Adult Inflammatory Myopathy
• Social security affiliation

Exclusion Criteria

• Pregnant and lactating women
• Patients unable to consent
• Patients refusing to participate in the research.
• Patients under legal protection

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Adult Autoimmune Myopathies	description of adult autoimmune myopathies	It is a description Autoimmune Myopathie cohort

Primary Outcome Measures

Name	Time	Method
Distribution of lymphocytes subpopulations (B, T and TH-17)	6 months	Distribution of lymphocytes subpopulations (B, T and TH-17) according to the final diagnosis defined by a panel of experts

Trial Locations

Locations (1)

CHU de BREST; 🇫🇷 Brest, France